Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Tarnow

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 2001
Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1P Hovind, L Tarnow, P Rossing, et al.
Kidney International. Supplement|July 21, 1999
Progression of diabetic nephropathy in normotensive type 1 diabetic patientsP Jacobsen, K Rossing, L Tarnow, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patientsM Lajer, L Tarnow, J Fleckner, et al.
Diabetes|June 1, 1997
Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in Caucasian patients with IDDML Tarnow, F Pociot, P M Hansen, et al.
Diabetologia|October 6, 2009
Telomere length predicts all-cause mortality in patients with type 1 diabetesA S Astrup, L Tarnow, A Jorsal, et al.
Diabetologia|May 25, 2010
QT interval prolongation during spontaneous episodes of hypoglycaemia in type 1 diabetes: the impact of heart rate correctionT F Christensen, L Tarnow, J Randløv, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2000
Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathyL Tarnow, C D Stehouwer, J J Emeis, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 30, 2001
Preventing diabetic nephropathy: an auditH P Hansen, S S Lund, P Rossing, et al.
Diabetes|March 1, 1996
Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathyL Tarnow, F Cambien, P Rossing, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 1996
Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathyL Tarnow, F Cambien, P Rossing, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 2001
Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1P Hovind, L Tarnow, P Rossing, et al.
Kidney International. Supplement|July 21, 1999
Progression of diabetic nephropathy in normotensive type 1 diabetic patientsP Jacobsen, K Rossing, L Tarnow, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patientsM Lajer, L Tarnow, J Fleckner, et al.
Diabetes|June 1, 1997
Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in Caucasian patients with IDDML Tarnow, F Pociot, P M Hansen, et al.
Diabetologia|October 6, 2009
Telomere length predicts all-cause mortality in patients with type 1 diabetesA S Astrup, L Tarnow, A Jorsal, et al.
Diabetologia|May 25, 2010
QT interval prolongation during spontaneous episodes of hypoglycaemia in type 1 diabetes: the impact of heart rate correctionT F Christensen, L Tarnow, J Randløv, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2000
Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathyL Tarnow, C D Stehouwer, J J Emeis, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 30, 2001
Preventing diabetic nephropathy: an auditH P Hansen, S S Lund, P Rossing, et al.
Diabetes|March 1, 1996
Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathyL Tarnow, F Cambien, P Rossing, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 1996
Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathyL Tarnow, F Cambien, P Rossing, et al.
Pageof 11